Read as much as you want on, anywhere and anytime, for just 99¢.

Mass. Mover

Ironwood stock posts a 3.3 percent gain

 Ironwood Pharmaceuticals is based in Cambridge.


Ironwood Pharmaceuticals is based in Cambridge.

Continue reading below

Ironwood Pharmaceuticals Inc. on Monday said that its new drug for irritable bowel syndrome with constipation is now available in the United States, marketed as Linzess (the trade name for linaclotide). It is estimated that irritable bowel syndrome afflicts 30 million to 40 million Americans. The stock rose Monday, fell Tuesday and Wednesday, then gained 3.2 percent Thursday. On Tuesday, Zacks upgraded the shares to “outperform,” with a $12 target price, said.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of